The risk for a dementia diagnosis before age 90 years was significantly higher among people with a history of PPI use, especially those who were diagnosed at a younger age.
Ensuring equitable access to medicines is a key challenge for many governments, particularly those of smaller nations. Pharmaceutical Technology reviews the data and explores European initiatives to improve the situation.
ABNCoV2 and the comparator vaccine demonstrated a reduced level of neutralizing antibodies against a circulating variant in Phase 3 study.cVLP platform has proven its ability to induce strong and.